Results 71 to 80 of about 43,174 (164)

Third Allogeneic Stem Cell Transplantation in Children: A Multicenter Analysis From the Spanish GETH‐TC Pediatric Group

open access: yesEuropean Journal of Haematology, Volume 117, Issue 4, Page 943-952, October 2026.
ABSTRACT Third allogeneic hematopoietic stem cell transplantation (HSCT3) is rarely performed in pediatric patients and is associated with high toxicity and mortality. Data on outcomes in this setting remain scarce. We conducted a retrospective multicenter study within the Spanish GETH‐TC Pediatric group including 29 children and adolescents who ...
Luisa Sisinni   +17 more
wiley   +1 more source

Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

open access: yes
Transfusion, EarlyView.
Nabiha H. Saifee   +24 more
wiley   +1 more source

Early Acute Kidney Injury in Allogeneic Hematopoietic Cell Transplantation: Incidence, Severity, and Associated Factors in a 634‐Recipient Cohort

open access: yesEuropean Journal of Haematology, Volume 117, Issue 4, Page 981-994, October 2026.
ABSTRACT Background Acute kidney injury (AKI) is a frequent and clinically relevant complication in allogeneic hematopoietic cell transplantation (HCT) recipients, particularly during the early post‐HCT period. Although AKI has been extensively reported in long‐term follow‐up studies, data focusing on the initial hospitalization phase remain limited ...
Luiz Carlos da Costa‐Junior   +10 more
wiley   +1 more source

Beyond the Kidney and Lung: Cutaneous and Mucosal Clues to Human Hantavirus Disease

open access: yesInternational Journal of Dermatology, Volume 65, Issue 10, Page 2018-2027, October 2026.
Rodent exposure and aerosolized excreta can lead to hantavirus infection with systemic endothelial injury and capillary leak, resulting in thrombocytopenia and syndromes such as HPS/HCPS and HFRS/NE. Early dermatologic and mucosal findings, including flushing, conjunctival injection, petechiae/purpura, and mucosal bleeding, may provide important clues ...
Giuseppe Gallo   +2 more
wiley   +1 more source

Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology. [PDF]

open access: yesBMC Nephrol, 2023
Von Tokarski F   +11 more
europepmc   +1 more source

Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies. [PDF]

open access: yesClin J Am Soc Nephrol, 2023
Werion A   +18 more
europepmc   +1 more source

Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review. [PDF]

open access: yesDiagnostics (Basel), 2023
Mocanu A   +10 more
europepmc   +1 more source

Thrombotic Microangiopathies (TMA)

open access: yes
Thrombotic Microangiopathies (TMAs). Ahmed Salman, MD, Hematologist/Medical Oncologist Objectives: Overview of different TMAs, diagnoses and treatment modalities Diagnose and differentiate between different TMAs Identify and implement management ...
Salman, Ahmed
core  

A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study

open access: yes, 2018
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microangiopathic hemolytic anemia and thrombocytopenia (MAHAT) associated with multiorgan dysfunction as a result of microvascular thrombosis and tissue ...
Sari, Ismail   +68 more
core   +1 more source

Home - About - Disclaimer - Privacy